Previous Article |
Table of Contents
| Next Article
(chemokine|genotype|leukocyte)
* Veterans Administration Research Center for AIDS and HIV-1
Infection and University of Texas Health Science Center, San Antonio,
TX 78229; Divisions of Edited by John M. Coffin, Tufts University School of Medicine,
Boston, MA, and approved August 7, 2002 (received for review June 14, 2002)
Studies in humans and in experimental models of HIV-1
infection indicate an important role for monocyte chemoattractant
protein-1 (MCP-1; also known as CC chemokine ligand 2), a potent
chemoattractant and activator of mononuclear phagocytes (MP) in the
pathogenesis of HIV-associated dementia (HAD). We determined the
influence of genetic variation in MCP-1 on HIV-1
pathogenesis in large cohorts of HIV-1-infected adults and children. In
adults, homozygosity for the MCP-1 -2578G allele was
associated with a 50% reduction in the risk of acquiring HIV-1.
However, once HIV-1 infection was established, this same
MCP-1 genotype was associated with accelerated disease
progression and a 4.5-fold increased risk of HAD. We examined the
molecular and cellular basis for these genotype-phenotype associations
and found that the mutant MCP-1 -2578G allele conferred
greater transcriptional activity via differential DNA-protein
interactions, enhanced protein production in vitro, increased serum MCP-1 levels, as well as MP infiltration into tissues.
Thus, MCP-1 expression had a two-edged role in HIV-1 infection: it
afforded partial protection from viral infection, but during infection,
its proinflammatory properties and ability to up-regulate HIV-1
replication collectively may contribute to accelerated disease
progression and increased risk of dementia. Our findings suggest that
MCP-1 antagonists may be useful in HIV-1 infection, especially for HAD,
and that HIV+ individuals possessing the MCP-1 -2578G
allele may benefit from early initiation of antiretroviral drugs that
effectively cross the blood-brain barrier. In a broader context, the
MCP-1 -2578G allele may serve as a genetic determinant of outcome of other disease states in which MP-mediated tissue injury
is central to disease pathogenesis.
From the Cover
Medical Sciences
HIV-1 infection and AIDS dementia are influenced by a mutant
MCP-1 allele linked to increased monocyte infiltration
of tissues and MCP-1 levels
,
,
,
,§,
,¶,
,
,
,
,
,
,¶¶, and
Nephrology and
¶ Cardiology, Ohio State University, Columbus, OH 43210;
§ Laboratorio de Biología Celular y Retrovirus and
§§ Servicio de Infectología, Hospital de
Pediatría "J. P. Garrahan," Combate de Los Pozos
1881 (1245), Buenos Aires, Argentina;
Forest
Laboratories, New York, NY 10022; ** Department of Pediatrics,
University of Utah, Salt Lake City, UT 84112; and 
Henry
M. Jackson Foundation and 
Infectious Diseases
Service, Wilford Hall Medical Center, Lackland AFB, TX 78236
E.G., B.H.R., L.S., G.C., and R.D. contributed
equally to this work.
www.pnas.org/cgi/doi/10.1073/pnas.202357499
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
D. D. G. Despriet, A. A. B. Bergen, J. E. Merriam, J. Zernant, G. R. Barile, R. T. Smith, I. A. Barbazetto, S. van Soest, A. Bakker, P. T. V. M. de Jong, et al. Comprehensive Analysis of the Candidate Genes CCL2, CCR2, and TLR4 in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Tse, N.-M. Tsang, K.-D. Chen, H.-P. Li, Y. Liang, C. Hsueh, K.-P. Chang, J.-S. Yu, S.-P. Hao, L.-L. Hsieh, et al. MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment Clin. Cancer Res., November 1, 2007; 13(21): 6320 - 6326. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Coll, S. Parra, C. Alonso-Villaverde, G. Aragones, M. Montero, J. Camps, J. Joven, and L. Masana The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection Stroke, September 1, 2007; 38(9): 2477 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ancuta, J. Wang, and D. Gabuzda CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J. Leukoc. Biol., November 1, 2006; 80(5): 1156 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Lehmann, S. Masanetz, S. Kramer, and V. Erfle HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner J. Cell Sci., November 1, 2006; 119(21): 4520 - 4530. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sui, S. Fan, L. Sniderhan, E. Reisinger, A. Litzburg, G. Schifitto, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation J. Immunol., July 1, 2006; 177(1): 702 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Brenner, J. Labreuche, P.-J. Touboul, K. Schmidt-Petersen, O. Poirier, C. Perret, J. Schonfelder, C. Combadiere, M. Lathrop, F. Cambien, et al. Cytokine Polymorphisms Associated With Carotid Intima-Media Thickness in Stroke Patients Stroke, July 1, 2006; 37(7): 1691 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ancuta, P. Autissier, A. Wurcel, T. Zaman, D. Stone, and D. Gabuzda CD16+ Monocyte-Derived Macrophages Activate Resting T Cells for HIV Infection by Producing CCR3 and CCR4 Ligands J. Immunol., May 15, 2006; 176(10): 5760 - 5771. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A.J. Cysique, P. Maruff, and B. J. Brew Variable benefit in neuropsychological function in HIV-infected HAART-treated patients Neurology, May 9, 2006; 66(9): 1447 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Bissel, G. Wang, A. M. Trichel, M. Murphey-Corb, and C. A. Wiley Longitudinal Analysis of Monocyte/Macrophage Infection in Simian Immunodeficiency Virus-Infected, CD8+ T-Cell-Depleted Macaques that Develop Lentiviral Encephalitis Am. J. Pathol., May 1, 2006; 168(5): 1553 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Ragin, Y. Wu, P. Storey, B. A. Cohen, R. R. Edelman, and L. G. Epstein Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection Neurology, April 25, 2006; 66(8): 1255 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Stamatovic, O. B. Dimitrijevic, R. F. Keep, and A. V. Andjelkovic Protein Kinase C{alpha}-RhoA Cross-talk in CCL2-induced Alterations in Brain Endothelial Permeability J. Biol. Chem., March 31, 2006; 281(13): 8379 - 8388. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Eugenin, K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman CCL2/Monocyte Chemoattractant Protein-1 Mediates Enhanced Transmigration of Human Immunodeficiency Virus (HIV)-Infected Leukocytes across the Blood-Brain Barrier: A Potential Mechanism of HIV-CNS Invasion and NeuroAIDS J. Neurosci., January 25, 2006; 26(4): 1098 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mahad, M. K. Callahan, K. A. Williams, E. E. Ubogu, P. Kivisakk, B. Tucky, G. Kidd, G. A. Kingsbury, A. Chang, R. J. Fox, et al. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis Brain, January 1, 2006; 129(1): 212 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Flores-Villanueva, J. A. Ruiz-Morales, C.-H. Song, L. M. Flores, E.-K. Jo, M. Montano, P. F. Barnes, M. Selman, and J. Granados A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis J. Exp. Med., December 19, 2005; 202(12): 1649 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Sheng, S. Hu, H. T. Ni, T. N. Rowen, J. R. Lokensgard, and P. K. Peterson TNF-{alpha}-induced chemokine production and apoptosis in human neural precursor cells J. Leukoc. Biol., December 1, 2005; 78(6): 1233 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. McDermott, Q. Yang, S. Kathiresan, L. A. Cupples, J. M. Massaro, J. F. Keaney Jr, M. G. Larson, R. S. Vasan, J. N. Hirschhorn, C. J. O'Donnell, et al. CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study Circulation, August 23, 2005; 112(8): 1113 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang, J. Wujek, G. Kidd, T. T. He, A. Cardona, M. E. Sasse, E. J. Stein, J. Kish, M. Tani, I. F. Charo, et al. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice FASEB J, May 1, 2005; 19(7): 761 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Zink, J. Uhrlaub, J. DeWitt, T. Voelker, B. Bullock, J. Mankowski, P. Tarwater, J. Clements, and S. Barber Neuroprotective and Anti-Human Immunodeficiency Virus Activity of Minocycline JAMA, April 27, 2005; 293(16): 2003 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Peterson, J. S. Errett, T. Wei, D. E. Dimcheff, R. Ransohoff, W. A. Kuziel, L. Evans, and B. Chesebro MCP-1 and CCR2 Contribute to Non-Lymphocyte-Mediated Brain Disease Induced by Fr98 Polytropic Retrovirus Infection in Mice: Role for Astrocytes in Retroviral Neuropathogenesis J. Virol., June 15, 2004; 78(12): 6449 - 6458. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weber, E. Blair, C. V. Simpson, M. O'Hara, P. E. Blackburn, A. Rot, G. J. Graham, and R. J.B. Nibbs The Chemokine Receptor D6 Constitutively Traffics to and from the Cell Surface to Internalize and Degrade Chemokines Mol. Biol. Cell, May 1, 2004; 15(5): 2492 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ranga, R. Shankarappa, N. B. Siddappa, L. Ramakrishna, R. Nagendran, M. Mahalingam, A. Mahadevan, N. Jayasuryan, P. Satishchandra, S. K. Shankar, et al. Tat Protein of Human Immunodeficiency Virus Type 1 Subtype C Strains Is a Defective Chemokine J. Virol., March 1, 2004; 78(5): 2586 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fantuzzi, F. Spadaro, G. Vallanti, I. Canini, C. Ramoni, E. Vicenzi, F. Belardelli, G. Poli, and S. Gessani Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages Blood, October 1, 2003; 102(7): 2334 - 2337. [Abstract] [Full Text] [PDF] |
||||